Archive

Study uncovers simple way of predicting severe pain following breast cancer surgery

Written by Alex Burton | 28 Sep 2012

Women having surgery for breast cancer are up to three times more likely to have severe pain in the first week after surgery if they suffer from other… read more.

Two recent studies have shown that the addition of Naloxone to Oxycodone can help patients with constipation side effects without compromising on analgesic efficacy

Written by Alex Burton | 28 Sep 2012

The combination also appears to be cost effective. A randomized, double-blind, active-controlled, double-dummy, parallel-group study to determine the safety and efficacy of oxycodone/naloxone prolonged-release tablets in patients with… read more.

Biologists find the cause of pain in the treatment of fair skin cancer

Written by Alex Burton | 28 Sep 2012

Pain caused by 2 different mechanisms Apply the ointment, light on, light off – that’s how easy it is to cure various forms of non-melanoma skin cancer. However,… read more.

ESC 2012 Report – Normal weight and belly fat spells higher risk of CVD than obesity only

Written by Bruce Sylvester | 17 Sep 2012

by Bruce Sylvester – Normal weight persons with weight concentrated in their belly run a higher death risk of CVD-related death than obese-only individuals, researchers reported at ESC.

ESC 2012 Report – Normal weight individuals with belly fat at highest CVD risk

Written by Lorraine Carolan | 17 Sep 2012

by Zara Qadir – BMI still offers a simple numeric measure of a person’s “thickness” or “thinness”. However, normal weight individuals who carry weight concentrated in their belly… read more.

ESC 2012 Report – Cholesterol and risk: past, present and future – The benefits of adding newer cholesterol-lowering agents to the statins

Written by Lorraine Carolan | 17 Sep 2012

by Zara Qadir – ESC Geoffrey Rose Lecture on Population Sciences. The recipient of the ‘ESC Geoffrey Rose Lecture on Population Sciences’ went to Rory Collins (pictured), who… read more.

ESC 2012 Report – Metabolically healthy, fit obese persons appear to have normal CVD and cancer risks

Written by Bruce Sylvester | 17 Sep 2012

by Bruce Sylvester – Obese persons who are metabolically healthy and fit have no more risk of developing or dying from cardiovascular disease or cancer than persons of… read more.

Ganitumab disappoints in pancreatic cancer: Amgen halts Phase III Study

Written by Charlie King | 3 Sep 2012

In a press release on August 8, 2012, Amgen announced that the company was halting a late-stage trial of its monoclonal antibody IGF-1 receptor antagonist ganitumab (AMG-479).

T-DM1 demonstrates overall survival benefit in metastatic breast cancer: Next target, FDA approval

Written by Charlie King | 3 Sep 2012

In news that is bound to excite breast cancer patients and investors, Genentech/Roche/Immunogen issued press releases on August 26, 2012, confirming that their drug-of-the-moment T-DM1 (trastuzumab emtansine) offers… read more.

ATC 2012 Report – Pancreatectomy and auto islet transplantation works well in children

Written by Lorraine Carolan | 21 Aug 2012

by Thomas R. Collins – Total pancreatectomy and auto islet transplantation among children can bring about good results, with many able to stay insulin-free and almost all of… read more.

ATC 2012 Report – Cancer expert sheds light on immune system

Written by Lorraine Carolan | 21 Aug 2012

by Thomas R. Collins – BOSTON — The transplantation community turned to a somewhat unlikely source for insight here as immunologist James Allison, PhD, Chairman of the Immunology Program… read more.

EAHP 2012 Report – Report of plenary lecture – The evolution of cancer treatment

Written by Christine Clark | 3 Aug 2012

by Christine Clark – Changes in the diagnosis and treatment of cancer form the basis for future developments. There have been many revolutions in medical science over the… read more.

« Previous 1 … 39 40 41 42 43 … 48 Next »

Archive

Subscribe for our mailing list

Follow Us